Cargando…
Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model
Background: Heightened levels of inflammation and oxidative stress are thought to be involved in the pathophysiology of schizophrenia. We aimed to assess whether intake of anti-inflammatory and anti-oxidant drugs during pregnancy prevents later schizophrenia-related outcomes in a neurodevelopmental...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215079/ https://www.ncbi.nlm.nih.gov/pubmed/37237933 http://dx.doi.org/10.3390/antiox12051068 |
_version_ | 1785047977679650816 |
---|---|
author | Edemann-Callesen, Henriette Bernhardt, Nadine Hlusicka, Elizabeth Barroeta Hintz, Franziska Habelt, Bettina Winter, Rebecca Neubert, Isabell Pelz, Meike Filla, Alexandra Soto-Montenegro, Maria Luisa Winter, Christine Hadar, Ravit |
author_facet | Edemann-Callesen, Henriette Bernhardt, Nadine Hlusicka, Elizabeth Barroeta Hintz, Franziska Habelt, Bettina Winter, Rebecca Neubert, Isabell Pelz, Meike Filla, Alexandra Soto-Montenegro, Maria Luisa Winter, Christine Hadar, Ravit |
author_sort | Edemann-Callesen, Henriette |
collection | PubMed |
description | Background: Heightened levels of inflammation and oxidative stress are thought to be involved in the pathophysiology of schizophrenia. We aimed to assess whether intake of anti-inflammatory and anti-oxidant drugs during pregnancy prevents later schizophrenia-related outcomes in a neurodevelopmental rat model of this disorder. Methods: Pregnant Wistar rats were injected with polyriboinosinic–polyribocytidilic acid (Poly I:C) or saline and subsequently treated with either N-acetyl cysteine (NAC) or omega-3 polyunsaturated fatty acids (PUFAs) until delivery. Controls rats received no treatment. In the offspring, neuroinflammation and anti-oxidant enzyme activity were assessed on postnatal day (PND) 21, 33, 48, and 90. Behavioral testing was performed at PND 90, followed by post-mortem neurochemical assessment and ex vivo MRI. Results: The supplement treatment led to a quicker restoration of the wellbeing of dams. In the adolescent Poly I:C offspring, the supplement treatment prevented an increase in microglial activity and partially prevented a deregulation in the anti-oxidant defense system. In the adult Poly I:C offspring, supplement treatment partially prevented dopamine deficits, which was paralleled by some changes in behavior. Exposure to omega-3 PUFAs prevented the enlargement of lateral ventricles. Conclusion: Intake of over-the-counter supplements may assist in especially targeting the inflammatory response related to schizophrenia pathophysiology, aiding in diminishing later disease severity in the offspring. |
format | Online Article Text |
id | pubmed-10215079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102150792023-05-27 Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model Edemann-Callesen, Henriette Bernhardt, Nadine Hlusicka, Elizabeth Barroeta Hintz, Franziska Habelt, Bettina Winter, Rebecca Neubert, Isabell Pelz, Meike Filla, Alexandra Soto-Montenegro, Maria Luisa Winter, Christine Hadar, Ravit Antioxidants (Basel) Article Background: Heightened levels of inflammation and oxidative stress are thought to be involved in the pathophysiology of schizophrenia. We aimed to assess whether intake of anti-inflammatory and anti-oxidant drugs during pregnancy prevents later schizophrenia-related outcomes in a neurodevelopmental rat model of this disorder. Methods: Pregnant Wistar rats were injected with polyriboinosinic–polyribocytidilic acid (Poly I:C) or saline and subsequently treated with either N-acetyl cysteine (NAC) or omega-3 polyunsaturated fatty acids (PUFAs) until delivery. Controls rats received no treatment. In the offspring, neuroinflammation and anti-oxidant enzyme activity were assessed on postnatal day (PND) 21, 33, 48, and 90. Behavioral testing was performed at PND 90, followed by post-mortem neurochemical assessment and ex vivo MRI. Results: The supplement treatment led to a quicker restoration of the wellbeing of dams. In the adolescent Poly I:C offspring, the supplement treatment prevented an increase in microglial activity and partially prevented a deregulation in the anti-oxidant defense system. In the adult Poly I:C offspring, supplement treatment partially prevented dopamine deficits, which was paralleled by some changes in behavior. Exposure to omega-3 PUFAs prevented the enlargement of lateral ventricles. Conclusion: Intake of over-the-counter supplements may assist in especially targeting the inflammatory response related to schizophrenia pathophysiology, aiding in diminishing later disease severity in the offspring. MDPI 2023-05-09 /pmc/articles/PMC10215079/ /pubmed/37237933 http://dx.doi.org/10.3390/antiox12051068 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Edemann-Callesen, Henriette Bernhardt, Nadine Hlusicka, Elizabeth Barroeta Hintz, Franziska Habelt, Bettina Winter, Rebecca Neubert, Isabell Pelz, Meike Filla, Alexandra Soto-Montenegro, Maria Luisa Winter, Christine Hadar, Ravit Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model |
title | Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model |
title_full | Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model |
title_fullStr | Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model |
title_full_unstemmed | Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model |
title_short | Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model |
title_sort | supplement treatment with nac and omega-3 polyunsaturated fatty acids during pregnancy partially prevents schizophrenia-related outcomes in the poly i:c rat model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215079/ https://www.ncbi.nlm.nih.gov/pubmed/37237933 http://dx.doi.org/10.3390/antiox12051068 |
work_keys_str_mv | AT edemanncallesenhenriette supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT bernhardtnadine supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT hlusickaelizabethbarroeta supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT hintzfranziska supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT habeltbettina supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT winterrebecca supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT neubertisabell supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT pelzmeike supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT fillaalexandra supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT sotomontenegromarialuisa supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT winterchristine supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel AT hadarravit supplementtreatmentwithnacandomega3polyunsaturatedfattyacidsduringpregnancypartiallypreventsschizophreniarelatedoutcomesinthepolyicratmodel |